Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares traded 69.53% higher at $3.95 on Wall Street last session.
SNOA stock price is now 51.78% away from the 50-day moving average and 15.53% away from the 200-day moving average. The market capitalization of the company currently stands at $6.37M.
In other news, Gottfurcht Grant, 10% Owner bought 86,111 shares of the company’s stock on Jan 03 ’25. The stock was bought for $232,500 at an average price of $2.70. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 02 ’25, Open Market Gottfurcht Grant bought 30,000 shares of the business’s stock. A total of $80,684 was incurred on buying the stock at an average price of $2.69. A total of 1.30% of the company’s stock is owned by insiders.
During the past 12 months, Sonoma Pharmaceuticals Inc has had a low of $1.75 and a high of $9.37. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 3.29, and a quick ratio of 2.44. The fifty day moving average price for SNOA is $2.5758 and a two-hundred day moving average price translates $3.4345 for the stock.
The latest earnings results from Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) was released for 2024-12-31. The net profit margin was -26.82% and return on equity was -64.83% for SNOA. The company reported revenue of $3.56 million for the quarter, compared to $3.14 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.58 percent. For the current quarter, analysts expect SNOA to generate $4.44M in revenue.
